| Cell line | RRID | Growth medium (FBS: heat-inactivated fetal bovine serum; P/S: penicillin/streptomycin) |
Temp | CO2 |
|---|---|---|---|---|
| 184-B5 | CVCL_4688 | MEBM (Lonza/Clonetics; MEGM Kit #CC-3150) + 1ng/ml cholera toxin (unfiltered) | 37°C | 5% |
| AU-565 | CVCL_1074 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| BT-20 | CVCL_0178 | EMEM + 10% FBS + 1% P/S | 37°C | 5% |
| BT-474 | CVCL_0179 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| BT-483 | CVCL_2319 | RPMI-1640 + 20% FBS + 1% P/S + 0.01mg/ml bovine insulin | 37°C | 5% |
| BT-549 | CVCL_1092 | RPMI-1640 + 10% FBS + 1% P/S + 0.023IU/ml insulin | 37°C | 5% |
| CAL-120 | CVCL_1104 | DMEM + 10% FBS + 1% P/S | 37°C | 5% |
| CAL-51 | CVCL_1110 | DMEM + 20% FBS + 1% P/S | 37°C | 5% |
| CAL-85-1 | CVCL_1114 | DMEM + 10% FBS + 1% P/S | 37°C | 5% |
| CAMA-1 | CVCL_1115 | EMEM + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1143 | CVCL_1245 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1395 | CVCL_1249 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1419 | CVCL_1251 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1428 | CVCL_1252 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1500 | CVCL_1254 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1569 | CVCL_1255 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1806 | CVCL_1258 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1937 | CVCL_0290 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC1954 | CVCL_1259 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC202 | CVCL_2062 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC38 | CVCL_1267 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| HCC70 | CVCL_1270 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| Hs 578T | CVCL_0332 | DMEM + 10% FBS + 1% P/S | 37°C | 5% |
| hTERT-HME1 | CVCL_3383 | MEBM + Lonza CC-3150 kit | 37°C | 5% |
| MCF-10A | CVCL_0598 | 1:1 DMEM and Ham’s F12 + 20ng/ml human epidermal growth factor + 100ng/ml cholera toxin + 0.01mg/ml bovine insulin + 500ng/ml hydrocortisone, 95% + 5% horse serum | 37°C | 5% |
| MCF-10F | CVCL_3633 | 1:1 DMEM and Ham’s F12 + 20ng/ml human epidermal growth factor + 100ng/ml cholera toxin + 0.01mg/ml bovine insulin + 500ng/ml hydrocortisone, 95% + 5% horse serum | 37°C | 5% |
| MCF-12A | CVCL_3744 | 1:1 DMEM and Ham’s F12 + 20ng/ml human epidermal growth factor + 100ng/ml cholera toxin + 0.01mg/ml bovine insulin + 500ng/ml hydrocortisone, 95% + 5% horse serum | 37°C | 5% |
| MCF-7 | CVCL_0031 | DMEM + 10% FBS + 1% P/S | 37°C | 5% |
| MDA-MB-134-VI | CVCL_0617 | Leibovitz’s L-15 + 20% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| MDA-MB-157 | CVCL_0618 | Leibovitz’s L-15 +10% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| MDA-MB-175-VII | CVCL_1400 | Leibovitz’s L-15 +10% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| MDA-MB-231 | CVCL_0062 | DMEM (or L-15) + 10% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| MDA-MB-361 | CVCL_0620 | Leibovitz’s L-15 + 20% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| MDA-MB-415 | CVCL_0621 | Leibovitz’s L-15 + 15% FBS (not heat-inactivated) + 1% P/S + 2mM L-glutamine + 10mg/l insulin | 37°C | 0% |
| MDA-MB-436 | CVCL_0623 | Leibovitz’s L-15 + 10% FBS (not heat-inactivated) + 1% P/S + 10mg/l insulin | 37°C | 0% |
| MDA-MB-453 | CVCL_0418 | Leibovitz’s L-15 + 10% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| MDA-MB-468 | CVCL_0419 | Leibovitz’s L-15 + 10% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| SK-BR-3 | CVCL_0033 | McCoy’s 5a + 10% FBS + 1% P/S | 37°C | 0% |
| SUM102PT | CVCL_3421 | Ham’s F-12 + 1% P/S + 5 μg/ml insulin + 1ug/ml hydrocortisone + 10ng/mL epidermal growth factor + 5mM ethanolamine + 10mM HEPES + 5ug/mL transferrin + 10nM T3 + 50nM sodium selenite + 1g/L BSA | 37°C | 5% |
| SUM1315MO2 | CVCL_5589 | Ham’s F-12 + 5% FBS + 1% P/S + 10ng/ml human epidermal growth factor + 5μg/ml insulin + 10 mM HEPES | 37°C | 5% |
| SUM149PT | CVCL_3422 | Ham’s F-12 + 5% FBS + 1% P/S + 1ug/ml hydrocortisone + 5μg/ml insulin + 10mM HEPES | 37°C | 5% |
| SUM159PT | CVCL_5423 | Ham’s F-12 + 5% FBS + 1% P/S + 1ng/ml hydrocortisone + 5μg/ml insulin + 10mM HEPES | 37°C | 5% |
| SUM225CWN | CVCL_5593 | Ham’s F-12 + 5% FBS + 1% P/S + 5μg/ml insulin + 1ug/ml hydrocortisone + 10mM HEPES | 37°C | 5% |
| SUM44PE | CVCL_3424 | Ham’s F-12 + 1% P/S + 5μg/ml insulin + 1ug/ml hydrocortisone + 5mM ethanolamine + 10mM HEPES + 5ug/mL transferrin + 10nM T3 + 50nM sodium selenite + 1g/L BSA | 37°C | 5% |
| SUM52PE | CVCL_3425 | Ham’s F-12 + 5% FBS + 1% P/S + 5 μg/ml insulin + 1ug/ml hydrocortisone + 10mM HEPES | 37°C | 5% |
| T-47D | CVCL_0553 | RPMI-1640 + 10% FBS + 1% P/S + 0.2units/ml bovine insulin | 37°C | 5% |
| UACC-812 | CVCL_1781 | Leibovitz’s L-15 + 20% FBS (not heat-inactivated) + 1% P/S + 2mM L-glutamine + 20ng/ml human EGF | 37°C | 0% |
| UACC-893 | CVCL_1782 | Leibovitz’s L-15 + 10% FBS (not heat-inactivated) + 1% P/S | 37°C | 0% |
| ZR-75-1 | CVCL_0588 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |
| ZR-75-30 | CVCL_1661 | RPMI-1640 + 10% FBS + 1% P/S | 37°C | 5% |